title: Macrophage-stimulating peptides VKGFY and cyclo(VKGFY) act through nonopioid beta-endorphin receptors.
abstract: We have synthesized two peptides, VKGFY and cyclo(VKGFY) (referred to as pentarphin (PNT) and cyclopentarphin (cPNT), respectively), and found that both peptides at 1 nM concentration increased the adhesion and spreading of murine peritoneal macrophages as well as their bactericidal activity in vitro, as shown by phagocytosis of Salmonella typhimurium virulent strain 415. PNT administered intraperitoneally at dose 20 microg/mouse on day 7, 3, and 1 prior to the isolation of macrophages also enhanced the macrophage adhesion and spreading. The receptor binding characteristics of PNT and cPNT were examined using 125I-labeled PNT. The binding of labeled PNT to peritoneal macrophages was high-affinity (K(d)=3.6 nM) and saturable. It was not inhibited by naloxone (NAL) or [Met(5)]enkephalin ([Met(5)]ENK) but completely inhibited by unlabeled cPNT (K(i)=2.6 nM), immunorphin (IMN, decapeptide SLTCLVKGFY, corresponding to the IgG heavy-chain sequence 364-373) (K(i)=3.2 nM) or beta-endorphin (beta-END) (K(i)=2.8 nM). Thus, the effects of PNT and cPNT on macrophages are mediated by NAL-insensitive receptors common for PNT, cPNT, IMN, and beta-END.
authors.affiliation: Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Science Avenue 6, 142290 Pushchino, Moscow Region, Russia. navolots@fibkh.serpukhov.su
authors.forename: E V
authors.initials: EV
authors.lastname: Navolotskaya
authors.forename: T A
authors.initials: TA
authors.lastname: Zargarova
authors.forename: N V
authors.initials: NV
authors.lastname: Malkova
authors.forename: T Yu
authors.initials: TY
authors.lastname: Zharmukhamedova
authors.forename: A A
authors.initials: AA
authors.lastname: Kolobov
authors.forename: E A
authors.initials: EA
authors.lastname: Kampe-Nemm
authors.forename: V V
authors.initials: VV
authors.lastname: Yurovsky
authors.forename: V M
authors.initials: VM
authors.lastname: Lipkin
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D002448:Cell Adhesion / Q000187:drug effects; D002478:Cells, Cultured; D007127:Immunoglobulin Constant Regions; D007142:Immunoglobulin gamma-Chains; D008262:Macrophage Activation; D008264:Macrophages / Q000187:drug effects*; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009842:Oligopeptides / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D010446:Peptide Fragments / Q000378:metabolism; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D010587:Phagocytosis; D011957:Receptors, Opioid / Q000819:agonists* / Q000378:metabolism; D001615:beta-Endorphin / Q000378:metabolism
chemical_list: D007127:Immunoglobulin Constant Regions; D007142:Immunoglobulin gamma-Chains; D009842:Oligopeptides; D010446:Peptide Fragments; D010455:Peptides; D010456:Peptides, Cyclic; D011957:Receptors, Opioid; C474115:cyclo(valyl-lysyl-glycyl-phenylalanyl-tyrosyl); C445661:immunorphin; C474114:valyl-lysyl-glycyl-phenylalanyl-tyrosine; D001615:beta-Endorphin